Valeant's New CEO Says Key Assets Can Be Sold
June 14, 2016 at 17:16 PM EDT
After months of confusion, Valeant Pharmaceutical’s new chief said Tuesday the troubled company is looking to sell assets to reduce its massive debt load—including its crown jewel, the Bausch & Lomb.
